{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:58:40Z","timestamp":1790546320244,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e36616","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T05:50:05Z","timestamp":1724392205000},"page":"e36616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Functional exploration and drug prediction on programmed cell death-related biomarkers in lung adenocarcinoma"],"prefix":"10.1016","volume":"10","author":[{"given":"Xugang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taorui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.heliyon.2024.e36616_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071759","article-title":"Lung adenocarcinoma tumor origin: a guide for personalized medicine","volume":"14","author":"Seguin","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib2","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: a cancer journal for clinicians"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36616_bib3","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5444","article-title":"Exploring histopathological and serum biomarkers in lung adenocarcinoma: clinical applications and translational opportunities","volume":"61","author":"Ortega","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36616_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030384","article-title":"Immune resistance in lung adenocarcinoma","volume":"13","author":"Spella","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e36616_bib5","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.21037\/tcr-21-1037","article-title":"Molecular typing of lung adenocarcinoma with computed tomography and CT image-based radiomics: a narrative review of research progress and prospects","volume":"10","author":"Ma","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36616_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36616_bib7","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1245\/s10434-012-2754-z","article-title":"KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapy","volume":"20","author":"Guan","year":"2013","journal-title":"Ann. Surg Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36616_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41419-017-0063-y","article-title":"Cell death-based treatment of lung adenocarcinoma","volume":"9","author":"Denisenko","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e36616_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2022.09.022","article-title":"Programmed cell death: past, present and future","volume":"633","author":"Kopeina","year":"2022","journal-title":"Biochem. Biophys. Res. Co."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36616_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","article-title":"Emerging connectivity of programmed cell death pathways and its physiological implications","volume":"21","author":"Bedoui","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7\u20138","key":"10.1016\/j.heliyon.2024.e36616_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10495-022-01735-y","article-title":"Programmed cell death detection methods: a systematic review and a categorical comparison","volume":"27","author":"Kari","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.heliyon.2024.e36616_bib12","article-title":"Programmed cell death tunes tumor immunity","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e36616_bib13","article-title":"A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36616_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.21037\/jtd-23-1275","article-title":"Exploring diverse programmed cell-death patterns to develop a novel gene signature for predicting the prognosis of lung adenocarcinoma patients","volume":"16","author":"Ma","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36616_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13030476","article-title":"A comprehensive analysis of programmed cell death-associated genes for tumor microenvironment evaluation promotes precise immunotherapy in patients with lung adenocarcinoma","volume":"13","author":"Huang","year":"2023","journal-title":"J. Personalized Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36616_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41436-019-0672-1","article-title":"Diagnostic utility of transcriptome sequencing for rare Mendelian diseases","volume":"22","author":"Lee","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.heliyon.2024.e36616_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2021.03.005","article-title":"Applications of single-cell and bulk RNA sequencing in onco-immunology","volume":"149","author":"Kuksin","year":"2021","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36616_bib18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1101\/pdb.top084970","article-title":"RNA sequencing and analysis","volume":"2015","author":"Kukurba","year":"2015","journal-title":"Cold Spring Harb. Protoc."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e36616_bib19","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s11033-021-06963-0","article-title":"RNA sequencing and its applications in cancer and rare diseases","volume":"49","author":"Ergin","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.heliyon.2024.e36616_bib20","article-title":"Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12935-023-03125-z","article-title":"Leveraging a disulfidptosis\/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma","volume":"23","author":"Ma","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12967-023-04468-x","article-title":"Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma","volume":"21","author":"Qin","year":"2023","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36616_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e36616_bib24","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/0008-5472.CAN-13-1616","article-title":"Integrative radiogenomic profiling of squamous cell lung cancer","volume":"73","author":"Abazeed","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e36616_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e36616_bib26","doi-asserted-by":"crossref","first-page":"W317","DOI":"10.1093\/nar\/gkab447","article-title":"KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis","volume":"49","author":"Bu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e36616_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1078200","article-title":"A signal recognition particle-related joint model of LASSO regression, SVM-RFE and artificial neural network for the diagnosis of systemic sclerosis-associated pulmonary hypertension","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.heliyon.2024.e36616_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.heliyon.2024.e36616_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e36616_bib30","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1007\/s10072-023-06845-2","article-title":"A comprehensive study of clinicopathological and genetic features of neuronal intranuclear inclusion disease","volume":"44","author":"Liu","year":"2023","journal-title":"Neurol. Sci."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e36616_bib31","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36616_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CTMethod","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36616_bib33","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36616_bib64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1573412919666230406100948","article-title":"Survey on multi-omics, and multi-omics data analysis, integration and application","volume":"19","author":"Shahrajabian","year":"2023","journal-title":"Curr. Pharm. Anal."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36616_bib34","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.18632\/aging.204112","article-title":"Identification of prognostic candidate signatures by systematically revealing transcriptome characteristics in lung adenocarcinoma with differing tumor microenvironment immune phenotypes","volume":"14","author":"Chen","year":"2022","journal-title":"Aging."},{"key":"10.1016\/j.heliyon.2024.e36616_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1062225","article-title":"Pyroptosis relates to tumor microenvironment remodeling and prognosis: a pan-cancer perspective","volume":"13","author":"Khan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e36616_bib36","article-title":"A Novel Pyroptosis-Related Prognostic Signature for Lung Adenocarcinoma: Identification and Multi-Angle Verification","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12920-023-01604-w","article-title":"Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma","volume":"16","author":"Cui","year":"2023","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.heliyon.2024.e36616_bib38","article-title":"The prognosis and immune checkpoint blockade efficacy prediction of tumor-infiltrating immune cells in lung cancer","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2024.e36616_bib39","article-title":"The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2024.e36616_bib40","article-title":"Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"PeerJ"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36616_bib41","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/1759-7714.13497","article-title":"Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma","volume":"11","author":"Su","year":"2020","journal-title":"Thoracic cancer"},{"key":"10.1016\/j.heliyon.2024.e36616_bib42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2023.10.035","article-title":"SIRP-alpha-IL-6 axis induces immunosuppressive macrophages in non-small-cell lung cancer","volume":"682","author":"Wang","year":"2023","journal-title":"Biochem. Biophys. Res. Co."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e36616_bib44","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.3390\/ijms19092729","article-title":"The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e36616_bib43","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1002\/jcp.30166","article-title":"The role of toll\u2010like receptor 4 (TLR4) in cancer progression: a possible therapeutic target?","volume":"236","author":"Kashani","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/oncologie-2023-0360","article-title":"A novel immune-associated prognostic signature based on the immune cell infiltration analysis for hepatocellular carcinoma","volume":"26","author":"Lin","year":"2024","journal-title":"Oncologie"},{"key":"10.1016\/j.heliyon.2024.e36616_bib46","doi-asserted-by":"crossref","DOI":"10.1515\/oncologie-2024-0037","article-title":"How to optimize the immune checkpoint blockade therapy for cancers?","author":"Guo","year":"2024","journal-title":"Oncologie"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e36616_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/oncologie-2023-0417","article-title":"Prognostic value of a glycolysis and cholesterol synthesis related gene signature in osteosarcoma: implications for immune microenvironment and personalized treatment strategies","volume":"26","author":"Feng","year":"2024","journal-title":"Oncologie"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36616_bib49","article-title":"Barriers to immune cell infiltration in tumors","volume":"11","author":"Melssen","year":"2023","journal-title":"J. ImmunoTher."},{"key":"10.1016\/j.heliyon.2024.e36616_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.suronc.2007.10.043","article-title":"NK cell-mediated immune response against cancer","volume":"16","author":"Moretta","year":"2007","journal-title":"Surgical Oncology"},{"key":"10.1016\/j.heliyon.2024.e36616_bib51","article-title":"Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing","volume":"13","author":"Song","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e36616_bib52","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/cancers13081946","article-title":"The role of macrophages in cancer development and therapy","volume":"13","author":"Cendrowicz","year":"2021","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.heliyon.2024.e36616_bib53","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7150\/jca.42531","article-title":"Identification of the key genes and characterizations of tumor immune microenvironment in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC)","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36616_bib54","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s12032-010-9638-5","article-title":"Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma","volume":"28","author":"Zhang","year":"2011","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e36616_bib55","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","article-title":"Eosinophils: biological properties and role in health and disease","volume":"38","author":"Hogan","year":"2008","journal-title":"J Clinical Experimental Allergy"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12967-023-04418-7","article-title":"Eosinophils in the tumor microenvironment: implications for cancer immunotherapy","volume":"21","author":"Ghaffari","year":"2023","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e36616_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e36616_bib58","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.21037\/jtd-23-1688","article-title":"Transcription factor-target gene regulatory network analysis in human lung adenocarcinoma","volume":"15","author":"Huang","year":"2023","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7150\/ijbs.86160","article-title":"Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells","volume":"20","author":"Zheng","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e36616_bib60","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/abr.abr_97_21","article-title":"Effects of methadone on the toll-like receptor 4 expression in human non-small cell lung carcinoma A549 cell line using in-silico and in vitro techniques","volume":"11","author":"Vaseghi","year":"2022","journal-title":"Adv. Biomed. Res."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e36616_bib61","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1111\/bph.15763","article-title":"The antibiotic drug trimethoprim suppresses tumour growth and metastasis via targeting Snail","volume":"179","author":"Ren","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e36616_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrc3237","article-title":"Combining immunotherapy and targeted therapies in cancer treatment","volume":"12","author":"Vanneman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e36616_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","article-title":"Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer","volume":"22","author":"Ye","year":"2023","journal-title":"Mol. Cancer"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024126473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024126473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:39:23Z","timestamp":1790545163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024126473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":64,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024126473"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36616","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional exploration and drug prediction on programmed cell death-related biomarkers in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e36616"}}